CARDIOLOGY ROUNDUP: Low-sodium Diet and HF Risk; Hypertension in Patients Under 40, and ODYSSEY OUTCOMES

A curated selection of the top stories and editor’s picks from the DocWire News Cardiology section over the last week.  

ODYSSEY OUTCOMES: Alirocumab Lowers Second Heart Attack Risk 

The full results of the ODYSSEY OUTCOMES study, looking at PCSK9 inhibitor alirocumab for the reduction of second heart attack risk in patients who had survived a first heart attack.     

Study: Risks Seen in People Under 40 with Hypertension 

A new analysis suggesting increased risk for heart failure, stroke and other adverse outcomes in people under the age of 40 who have various stages of hypertension.   

Low-salt Diet May Not Reduce Risk of Heart Failure 

New evidence suggests that a low-sodium diet may have no effect on the risk for heart failure.   

Antihypertensive Medications Decrease Alzheimer’s Risk 

Several medications used to treat hypertension may also lower the risk for Alzheimer’s disease (AD) in certain patients, according to a new retrospective cohort study.   

 

DocWire News Cardiology Abstracts You May Have Missed 

High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention (Journal of the American Heart Association) 

Cardiorespiratory Fitness and Mortality in Healthy Men and Women (JACC) 

The Hypoxic Burden of Sleep Apnea Predicts Cardiovascular Disease-related Mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study (European Heart Journal) 

Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS) (Stroke)